Cyclooxygenase-2 polymorphisms and susceptibility to gastric carcinoma: A meta-analysis
查看参考文献38篇
文摘
|
AIM: To investigate the association of the cyclooxygenases-2(COX-2)polymorphisms and susceptibility to gastric cancer(GC)by means of meta-analysis. METHODS: Publications addressing the association between polymorphisms of COX-2 and susceptibility to GC were selected from the MEDLINE,EMBASE and CBMdisc databases. Data was extracted from the studies by 2 independent reviewers. The meta-analyses were performed by RevMan 5.0.23. From these data, odds ratio (OR)with 95%confidence interval(CI)was calculated. RESULTS: Ten studies were retrieved reporting a total of 11 COX-2 polymorphisms. Carriers of -765C,-1195A, -1290G,*2430T alleles and*429TT genotype revealed increased risk for GC(OR=1.71,95%CI:1.01-2.90,P =0.05;OR=1.58,95%CI:1.05-2.38,P=0.03;OR= 1.55,95%CI:1.01-2.39,P=0.05;OR=2.62,95%CI: 1.20-5.73,P=0.02 and OR=0.74,95%CI:0.59-0.95, P=0.02, respectively). CONCLUSION: The-765C,-1195A,-1290G,*2430T alleles and*429TT genotype of COX-2 polymorphisms were determined a significant association with susceptibility to GC |
来源
|
World Journal of Gastroenterology
,2010,16(43):5510-5517 【核心库】
|
关键词
|
Cyclooxygenases-2
;
Gastric cancer
;
Polymorphisms
;
Susceptibility
;
Meta-analysis
|
地址
|
1.
Department of Surgical Oncology and General Surgery, the First Affiliated Hospital of China Medical University, Liaoning, Shenyang, 110001
2.
Department of Oncology, the Shengjing Affiliated Hospital of China Medical University, Liaoning, Shenyang, 110001
3.
Department of Obstetrics and Gynecology, the Shengjing Affiliated Hospital of China Medical University, Liaoning, Shenyang, 110001
4.
Department of Oncology, the Fourth Affiliated Hospital of China Medical University, Liaoning, Shenyang, 110032
|
语种
|
英文 |
文献类型
|
研究性论文 |
ISSN
|
1007-9327 |
学科
|
内科学 |
基金
|
国家自然科学基金
;
key laboratory programme of Education Department of Liaoning Province
|
文献收藏号
|
CSCD:4051416
|
参考文献 共
38
共2页
|
1.
Crew KD. Epidemiology of gastric cancer.
World J Gastroenterol,2006,12:354-362
|
CSCD被引
90
次
|
|
|
|
2.
Parkin DM. International variation.
Oncogene,2004,23:6329-6340
|
CSCD被引
34
次
|
|
|
|
3.
Parkin DM. Estimates of the worldwide incidence of eighteen major cancers in 1985.
Int J Cancer,1993,54:594-606
|
CSCD被引
25
次
|
|
|
|
4.
Jemal A. Cancer statistics,2008.
CA Cancer J Clin,2008,58:71-96
|
CSCD被引
493
次
|
|
|
|
5.
Coussens LM. Inflammation and cancer.
Nature,2002,420:860-867
|
CSCD被引
354
次
|
|
|
|
6.
Marx J. Cancer research. Inflammation and cancer:the link grows stronger.
Science,2004,306:966-968
|
CSCD被引
17
次
|
|
|
|
7.
Ulrich CM. Non-steroidal anti-inflammatory drugs for cancer prevention:promise, perils and pharmacogenetics.
Nat Rev Cancer,2006,6:130-140
|
CSCD被引
10
次
|
|
|
|
8.
Vane JR. Mechanism of action of nonsteroidal anti-inflammatory drugs.
Am J Med,1998,104:2S-8S
|
CSCD被引
16
次
|
|
|
|
9.
Chandrasekharan NV. The cyclooxygenases.
Genome Biol,2004,5:241
|
CSCD被引
3
次
|
|
|
|
10.
Dubois RN. Cyclooxygenase in biology and disease.
FASEB J,1998,12:1063-1073
|
CSCD被引
55
次
|
|
|
|
11.
Bakhle YS. COX-2 and cancer:a new approach to an old problem.
Br J Pharmacol,2001,134:1137-1150
|
CSCD被引
4
次
|
|
|
|
12.
Yu LZ. Expression of COX-2 proteins in gastric mucosal lesions.
World J Gastroenterol,2004,10:292-294
|
CSCD被引
4
次
|
|
|
|
13.
Souza RF. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
Cancer Res,2000,60:5767-5772
|
CSCD被引
20
次
|
|
|
|
14.
Nithipatikom K. Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion.
Clin Exp Metastasis,2002,19:593-601
|
CSCD被引
5
次
|
|
|
|
15.
Tsujii M. Cyclooxygenase regulates angiogenesis induced by colon cancer cells.
Cell,1998,93:705-716
|
CSCD被引
142
次
|
|
|
|
16.
Fujimura T. Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers:a review and report of personal experience.
World J Gastroenterol,2006,12:1336-1345
|
CSCD被引
7
次
|
|
|
|
17.
Dixon DA. Regulation of COX-2 expression in human cancers.
Prog Exp Tumor Res,2003,37:52-71
|
CSCD被引
10
次
|
|
|
|
18.
Sitarz R. The COX-2 promoter polymorphism-765 G>C is associated with early-onset, conventional and stump gastric cancers.
Mod Pathol,2008,21:685-690
|
CSCD被引
5
次
|
|
|
|
19.
Attia J. Meta-analyses of molecular association studies:methodologic lessons for genetic epidemiology.
J Clin Epidemiol,2003,56:297-303
|
CSCD被引
15
次
|
|
|
|
20.
Vandenbroucke JP. Strengthening the Reporting of Observational Studies in Epidemiology(STROBE):explanation and elaboration.
Epidemiology,2007,18:805-835
|
CSCD被引
10
次
|
|
|
|
|